Several studies have been performed to evaluate changes in levels and relationships between laboratory biomarkers such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), lymphocytes (LYM), neutrophil (NEU), and lactate dehydrogenase (LDH) in patients with COVID-19 [3, 4]. This evidence concerns the gene GPT and COVID-19.